The U.S. Food and Drug Administration's (FDA) warning letter to Agena Bioscience, issued on March 21, 2024, marks a significant shift in enforcement priorities, targeting the improper labeling of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback